An Act amending the act of November 3, 2022 (P.L.2135, No.150), known as the Childhood Blood Lead Test Act, further providing for title of act, for legislative purpose, for definitions, for lead poisoning prevention, assessment and testing, for duties of department and for blood lead assessment and testing coverage.

Summary

HB 916 updates Pennsylvania’s Childhood Blood Lead Test Act by adding new findings, definitions, and testing requirements. Health‑care providers (or their certified assistants) must ensure at least one blood lead test for every child under 72 months, with follow‑up confirmatory testing if levels are high, and must screen high‑risk children annually. The bill also establishes testing guidelines for pregnant women and clarifies what constitutes lead poisoning.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share